Corey McCann Net Worth & Insider Trades

Corey McCann - President and CEO, Pear Therapeutics, Inc

As of February 17, 2023

What is Corey McCann's Net Worth?

The current estimated net worth of Pear Therapeutics, Inc's President and CEO, Corey McCann, is estimated to be about $655.92K . Corey McCann owns about 9,197,351 units of Pear Therapeutics, Inc common stock. In the last 2 years at Pear Therapeutics, Inc, Corey McCann has sold an estimated value of $39.25K worth.

What is Corey McCann's Past Insider Trading?

Corey McCann's largest sale order was 34,731 units , worth over $39.25K on January 24, 2023. In total, Corey McCann has made about 5 transactions over 2 years of their time at Pear Therapeutics, Inc. Corey McCann usually trades in January and February, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Corey McCann

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Corey McCann's' Mailing Address?

  • Mailing address is C/o Pear Therapeutics, Inc. 200 State Street, 13th Floor Boston MA 02109 MA

What are Pear Therapeutics, Inc's Past Insider Trades?

Pear Therapeutics, Inc's most recent insider trade came on April 12, 2023 by Am Partners Iv Llc, Am Ventures Iv Lp, Am Coinvestors Iv Lp, Am Opportunities I GP Llc, Am Opportunities I Lp, John Diekman, Scott Rocklage and Andrew Schwab who sold 16,544,113 units worth $1.99M . In the last year, insiders at Pear Therapeutics, Inc have sold an estimated value of $5.84M and bought an estimated value of $2.13M worth of shares. Insider trading is most common in December, with the busiest year in 2023. The most active traders at the company are Andrew Schwab,  Erin Brenner, Chief Product Dev. Officer,  and Am Coinvestors Iv Lp .

Pear Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...